Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| enVVeno Medical CorpHJLI · Entity 8104 | Director | November 27, 2018 | November 29, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
enVVeno Medical Corp
Report date November 27, 2018 · Filed November 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock unitsSEC Table I · non-derivative | Direct | 29,183 |
Reported balance
After 2018-11-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-11-27 · Grant · Acquired 29,183 · Balance 29,183 F1: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021. F2: Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.57 · Expires 2021-10-02 | Direct | 60,000 |
Reported balance
After 2018-11-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-27 · Grant · Acquired 60,000 · Balance 60,000 F3: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021.
F2: Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A.
F3: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2018 Filed Nov 29, 2018 22:31 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantStock Options · Derivative | 60,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001493152-18-016880 · ownership.xml · derivative · entry 2 Robins Marcus W. · CIK 0001755426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2021-10-02 F3 · security: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018. F3 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 22:31 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantRestricted Stock units | 29,183 | $2.57 | $75,000.31 |
DisclosureSEC source: 0001493152-18-016880 · ownership.xml · nonDerivative · entry 1 Robins Marcus W. · CIK 0001755426 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,183 F1 · security: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021. F2 · security: Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A. F1 · kind: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.